Comparative analysis of the kinomes of three pathogenic trypanosomatids: Leishmania major, Trypanosoma brucei and Trypanosoma cruzi.
Parsons M, Worthey EA, Ward PN, Mottram JC. · 2005
Read Comparative analysis of the kinomes of three pathogenic trypanosomatids: Leishmania major, Trypanosoma brucei and Trypanosoma cruzi. by Parsons M, Worthey EA, Ward PN, Mottram JC. (2005) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc1266030.txt.
Introduction
Parsons, Worthey, Ward, and Mottram catalogued kinase enzymes in three parasites in 2005. The parasites cause leishmaniasis, sleeping sickness, and Chagas disease. Kinases relay signals that pace their complex life cycles. Genome searches counted every kinase in each species.
Trypanosoma brucei held 176 kinases, and Trypanosoma cruzi held 190. Leishmania major held 199, the most of the three. Most kinases matched across all three species. The counts run near 30 percent of the human total. They double the malaria parasite count. Parsons supplies a target list for anti-parasite drug work. Each parasite shifts between insect hosts and mammal hosts across its life cycle in turn.
Catalog record
| CREATOR | Parsons M, Worthey EA, Ward PN, Mottram JC. |
|---|---|
| YEAR | 2005 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 79 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Comparative analysis of the kinomes of three pathogenic trypanosomatids: Leishmania major, Trypanosoma brucei and Trypanosoma cruzi By Marilyn Parsons, Elizabeth A Worthey, Pauline N Ward, Jeremy C Mottram Published in: BMC Genomics DOI: 10.1186/1471-2164-6-127 ABSTRACT Abstract Background The trypanosomatids Leishmania major, Trypanosoma brucei and Trypanosoma cruzi cause some of the most debilitating diseases of humankind: cutaneous leishmaniasis, African sleeping sickness, and Chagas disease. These protozoa possess complex life cycles that involve development in mammalian and insect hosts, and a tightly coordinated cell cycle ensures propagation of the highly polarized cells. However, the ways in which the parasites respond to their environment and coordinate intracellular processes are poorly understood. As a part of an effort to understand parasite signaling functions, we report the results of a genome-wide analysis of protein kinases (PKs) of these three trypanosomatids. Results Bioinformatic searches of the trypanosomatid genomes for eukaryotic PKs (ePKs) and atypical PKs (aPKs) revealed a total of 176 PKs in T. brucei, 190 in T. cruzi and 199 in L. major, most of which are orthologous across the three species. This is approximately 30% of the number in the human host and double that of the malaria parasite, Plasmodium falciparum. The representation of various groups of ePKs differs significantly as compared to humans: trypanosomatids lack receptor-linked tyrosine and tyrosine kinase-like kinases, although they do possess dual-specificity kinases. A relative expansion of the CMGC, STE and NEK groups has occurred. A large number of unique ePKs show no strong affinity to any known group. The trypanosomatids possess few ePKs with predicted transmembrane domains, suggesting that receptor ePKs are rare. Accessory Pfam domains, which are frequently present in human ePKs, are uncommon in trypanosomatid ePKs. Conclusion Trypanosomatids possess a large set of PKs, comprising approximately 2% of each genome, suggesting a key role for phosphorylation in parasite biology. Whilst it was possible to place most of the trypanosomatid ePKs into the seven established groups using bioinformatic analyses, it has not been possible to ascribe function based solely on sequence similarity. Hence the connection of stimuli to protein phosphorylation networks remains enigmatic. The presence of numerous PKs with significant sequence similarity to known drug targets, as well as a large number of unusual kinases that might represent novel targets, strongly argue for functional analysis of these molecules. BACKGROUND Trypanosomatid pathogens of humans include Trypanosoma brucei, Trypanosoma cruzi and Leishmania major, causative agents of African sleeping sickness, Chagas disease, and cutaneous leishmaniasis respectively [1]. Trypanosoma brucei lives extracellularly in the human host, primarily in the bloodstream and cerebrospinal fluid. African sleeping sickness, which is estimated to afflict 300,000–500,000 people per year in sub-Saharan Africa, with a disease burden of 1.6 million disability adjusted life years (DALYs), is invariably fatal unless treated [2]. Trypanosoma cruzi, which is found in Latin America, results in a disease burden of 650,000 DALYs. This parasite can invade most types of nucleated cells. About 30% of infected individuals progress to a chronic phase that culminates in heart disease and mega syndrome [3]. Of those infected it is estimated the 50,000 will die each year. Leishmania parasites result in a disease burden of 2.3 million DALYs, with greater than 80,000 deaths/year and cause a variety of diseases depending on the infecting species. The most dangerous manifestation is the visceral disease known as kala azar, caused by L. donovani. Kala azar is re-emerging in India in a particularly aggressive form that is resistant to standard treatment [4]. No vaccine has been approved for any of these diseases and many of the drugs in use are highly toxic and prone to the development of drug resistance. There is therefore an urgent need to identify new drug targets and the recent completion of the genome sequence of the three model trypanosomatids, T. brucei, T. cruzi and L. major, can be exploited in this regard [5-7]. During development the parasites pass through different environments. Each species is carried by a different insect vector, in which the parasite undergoes specific developmental changes that allow it to infect the human host. For example, Leishmania parasites move from the sandfly midgut up to the mouthparts, then into the human host where they invade macrophages and live within a phagolysosome. In each environment, the parasites respond with significant changes in their metabolic and protein profile. The signal transduction pathways mediating these changes remain unknown. Only a few receptor-like proteins have been identified, primarily receptor adenylate cyclases with an extracellular putative ligand binding domain and an intracellular catalytic domain [8,9]. Intermediate steps of signal transduction in the parasites have not been defined, although genomic analysis shows that they possess numerous molecules predicted to bind second messengers, as well as protein kinases and phosphatases [5]. The culmination of the signaling pathways is unlikely to be at the level of transcription, since most genes are transcribed in polycistronic units with little evidence for regulation [7,10,11]. Many changes in protein phosphorylation during the parasite developmental cycles have been documented [12-14]. The parasites also possess an integrated cell cycle that coordinates the inheritance of the single mitochondrion, flagellum, and nucleus [15,16]. Protein kinases (PKs) are key mediators of signal transduction, transmitting environmental cues and coordinating intracellular processes. Eukaryotic protein kinases (ePKs) are categorized by the amino acid sequence of their catalytic domains. Broadly, ePKs fall into two superfamilies: protein serine/threonine kinases and protein tyrosine kinases. The former are ubiquitous in eukaryotes. The latter are present in all metazoa for which the genome sequence is available, but relatively few examples have been found in unicellular eukaryotes [17,18]. However, protein tyrosine phosphorylation has been well documented in trypanosomatids [13,14,19,20]. Mammalian receptor protein kinases are generally tyrosine kinases [21], while all known plant receptor kinases are serine/threonine kinases [22,23]. Receptor kinases are activated by ligands, facilitating intercellular communication within multicellular organisms. Parasites that live in multicellular hosts could conceivably use similar mechanisms to respond to host or parasite ligands, although such reactions have not been defined at the molecular level. Six major groups of ePKs have been defined on the basis of sequence similarity of the catalytic domains: AGC, CAMK, CMGC, TK, TKL, STE [24]. ePKs that do not fall into these groups are categorized as "Other". Within each group (including "Other"), multiple families have been defined. Interestingly, the substrate preferences break into groups along the same lines: for example AGC and CAMK kinases tend to phosphorylate motifs containing basic residues, CMGC kinases often are proline-directed, while CK1 and CK2 kinases phosphorylate motifs with acidic residues [24]. Additional features that correlate with group assignments include responses to other mediators such as ligands (receptor TK), calcium (CAMK), and certain second messengers (AGC). Relatively few protein kinases have been studied in detail with respect to expression and function in each of the trypanosomatids (see Additional file 1). Atypical PKs (aPKs) are not closely related to ePKs at the sequence level, lacking the 11 subdomains that define ePKs. They include a variety of molecules that have been shown to have protein kinase catalytic activity in specific systems. Among the aPKs, the most well-characterized are the PIKK kinases, which have catalytic domains resembling those of lipid kinases in sequence [25]. Interestingly, the RIO and alpha groups show remnants of many of the ePK subdomain